Your browser doesn't support javascript.
loading
Dendritic Cells from HIV Controllers Have Low Susceptibility to HIV-1 Infection In Vitro but High Capacity to Capture HIV-1 Particles.
Hamimi, Chiraz; David, Annie; Versmisse, Pierre; Weiss, Laurence; Bruel, Timothée; Zucman, David; Appay, Victor; Moris, Arnaud; Ungeheuer, Marie-Noëlle; Lascoux-Combe, Caroline; Barré-Sinoussi, Françoise; Muller-Trutwin, Michaela; Boufassa, Faroudy; Lambotte, Olivier; Pancino, Gianfranco; Sáez-Cirión, Asier.
Affiliation
  • Hamimi C; Institut Pasteur, Régulation des Infections Rétrovirales, Paris, France.
  • David A; Institut Pasteur, HIV Inflammation et Persistance, Paris, France.
  • Versmisse P; Institut Pasteur, Régulation des Infections Rétrovirales, Paris, France.
  • Weiss L; Institut Pasteur, Régulation des Infections Rétrovirales, Paris, France.
  • Bruel T; AP-HP Hôpital Européen Georges Pompidou, Paris, France.
  • Zucman D; Université Paris Descartes; Sorbonne Paris-Cité; Paris, France.
  • Appay V; Université Paris Sud, UMR-1184, Le Kremlin-Bicêtre, France.
  • Moris A; CEA, DSV/iMETI, Division of Immuno-Virology, IDMIT, Fontenay-aux-Roses, France.
  • Ungeheuer MN; Hopital Foch, Service de médecine interne, Suresnes, France.
  • Lascoux-Combe C; Sorbonne Universités, UPMC Univ Paris 06, DHU FAST, CR7, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.
  • Barré-Sinoussi F; INSERM, U1135, CIMI-Paris, Paris, France.
  • Muller-Trutwin M; Sorbonne Universités, UPMC Univ Paris 06, DHU FAST, CR7, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.
  • Boufassa F; INSERM, U1135, CIMI-Paris, Paris, France.
  • Lambotte O; CNRS, ERL 8255, CIMI-Paris, Paris, France.
  • Pancino G; Institut Pasteur, Plate-forme Investigation Clinique et Accès aux Ressources Biologiques (ICAReB), Paris, France.
  • Sáez-Cirión A; AP-HP, Saint-Louis Hospital, Infectious Diseases Department, Paris, France.
PLoS One ; 11(8): e0160251, 2016.
Article in En | MEDLINE | ID: mdl-27505169
ABSTRACT
HIV controllers (HICs), rare HIV-1 infected individuals able to control viral replication without antiretroviral therapy, are characterized by an efficient polyfunctional and cytolytic HIV-specific CD8+ T cell response. The mechanisms underlying the induction and maintenance of such response in many HICs despite controlled viremia are not clear. Dendritic cells play a crucial role in the generation and reactivation of T cell responses but scarce information is available on those cells in HICs. We found that monocyte derived dendritic cells (MDDCs) from HICs are less permissive to HIV-1 infection than cells from healthy donors. In contrast MDDCs from HICs are particularly efficient at capturing HIV-1 particles when compared to cells from healthy donors or HIV-1 patients with suppressed viral load on antiretroviral treatment. MDDCs from HICs expressed on their surface high levels of syndecan-3, DC-SIGN and MMR, which could cooperate to facilitate HIV-1 capture. The combination of low susceptibility to HIV-1 infection but enhanced capacity to capture particles might allow MDDCs from HICs to preserve their function from the deleterious effect of infection while facilitating induction of HIV-specific CD8+ T cells by cross-presentation in a context of low viremia.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dendritic Cells / HIV Infections / HIV-1 Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2016 Document type: Article Affiliation country: Francia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dendritic Cells / HIV Infections / HIV-1 Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2016 Document type: Article Affiliation country: Francia